Home > Publications >Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells >

<<Previous Next>>

Post Date:Feb-08-22

Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells

AcceGenAuthor: AcceGen R&D Team

Date Published: 08-Feb-22

Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells

  • Authors: Wei-Ching Chen, Minh D. To, Peter M. K. Westcott, Reyno Delrosario, Il-Jin Kim, Mark Philips, Quan Tran, Saumya R. Bollam, Hani Goodarzi, Nora Bayani, Olga Mirzoeva & Allan Balmain
  • Journal: Nature Communications
  • DOI: 10.1038/s41467-021-24498-7
  • Cited AcceGen Product/Service: SUIT-2

<<Previous Next>>

AcceGen Scroll Top Button